Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Topotecan, Utilization for a Metronomic Dosing Schedule to Treat Recurrent or Persistent Solid Tumors

NCT00382733 is registered in ClinicalTrials.gov with Accelerated Community Oncology Research Network as lead sponsor.

NCT NCT00382733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00382733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Topotecan, Utilization for a Metronomic Dosing Schedule to Treat Recurrent or Persistent Solid Tumors
Lead sponsor
Accelerated Community Oncology Research Network
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2006
Completion date
March 31, 2011
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tumors